Royal Bank of Canada’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Royal Bank of Canada’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28	Closed	–	–	7845
2023 Q3	$0	Hold	28	–	–	﹤0.01%	7850
2023 Q2	$0	Buy	+28	New	+$477	﹤0.01%	7861
2022 Q4	–	Sell	-14	Closed	–	–	7970
2022 Q3	$0	Buy	+14	New	+$309	﹤0.01%	8065
2022 Q1	–	Sell	-313	Closed	-$5K	–	8149
2021 Q4	$5K	Buy	+313	New	+$6.55K	﹤0.01%	7237

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Royal Bank of Canada's ZIVO Position: Q4 2023 in Review

Royal Bank of Canada sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 28 shares.

Royal Bank of Canada first reported a position in ZIVO in Q4 2021 and held it in 4 quarters. The position peaked at $5K in Q4 2021. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Royal Bank of Canada reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Royal Bank of Canada sold 28 Zivo Bioscience, Inc. Common Stock shares in Q4 2023.
Royal Bank of Canada first reported a position in Zivo Bioscience, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Royal Bank of Canada's Zivo Bioscience, Inc. Common Stock position peaked at $5K in Q4 2021.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.